| Literature DB >> 31600890 |
Yuan-Feng Zou1, Yan-Yun Zhang2, Yu-Ping Fu3, Kari Tvete Inngjerdingen4, Berit Smestad Paulsen5, Bin Feng6, Zhong-Kai Zhu7, Li-Xia Li8, Ren-Yong Jia9, Chao Huang10, Xu Song11, Cheng Lv12, Gang Ye13, Xiao-Xia Liang14, Chang-Liang He15, Li-Zi Yin16,17, Zhong-Qiong Yin18,19.
Abstract
In this study, an acidic polysaccharide from Codonopsis pilosula Nannf. var. modesta (Nannf.) L. T. Shen (WCP-I) and its main fragment, WCP-Ia, obtained after pectinase digestion, were structurally elucidated and found to consist of a rhamnogalacturonan I (RG-I) region containing both arabinogalactan type I (AG-I) and type II (AG-II) as sidechains. They both expressed immunomodulating activity against Peyer's patch cells. Endo-1,4-β-galactanase degradation gave a decrease of interleukine 6 (IL-6) production compared with native WCP-I and WCP-Ia, but exo-α-l-arabinofuranosidase digestion showed no changes in activity. This demonstrated that the stimulation activity partly disappeared with removal of β-d-(1→4)-galactan chains, proving that the AG-I side chain plays an important role in immunoregulation activity. WCP-Ia had a better promotion effect than WCP-I in vivo, shown through an increased spleen index, higher concentrations of IL-6, transforming growth factor-β (TGF-β), and tumor necrosis factor-α (TNF-α) in serum, and a slight increment in the secretory immunoglobulin A (sIgA) and CD4+/CD8+ T lymphocyte ratio. These results suggest that β-d-(1→4)-galactan-containing chains in WCP-I play an essential role in the expression of immunomodulating activity. Combining all the results in this and previous studies, the intestinal immune system might be the target site of WCP-Ia.Entities:
Keywords: Codonopsis pilosula; Peyer’s patch; immunomodulation; polysaccharide
Mesh:
Substances:
Year: 2019 PMID: 31600890 PMCID: PMC6832355 DOI: 10.3390/molecules24203632
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Elution profiles. (A) elution profile of WCP by diethylaminoethyl (DEAE)-Sepharose Fast Flow; (B) size exclusion chromatography elution profile of fraction WCP-I (black) and its degradation product by pectinase (red).
Monosaccharide compositions (%) of WCP-I and its enzymatic degradation products.
| Samples | WCP-I | WCP-Ia | WCP-Ib | WCP-Ic |
|---|---|---|---|---|
| Arabinose (Ara) | 5.5 | 13.0 | 10.1 | 11.0 |
| Rhamnose (Rha) | 6.4 | 10.6 | 11.1 | 12.6 |
| Mannose (Man) | 0.7 | 0.8 | 0.5 | 0.6 |
| Galactose (Gal) | 17.6 | 37.5 | 42.3 | 38.1 |
| Glucose (Glc) | 0.2 | 0.3 | 0.6 | 0.7 |
| Galacturonic acid (GalA) | 69.6 | 37.8 | 35.4 | 37.0 |
Linkage elucidation of WCP-I and its pectinase degradation product WCP-Ia.
| WCP-I | WCP-Ia | ||
|---|---|---|---|
| Ara | T | 2.8 | 6.7 |
| 1→2 | 1.3 | 2.9 | |
| 1→3 | 1.4 | 3.3 | |
| Rha | 1→2 | 3.3 | 5.5 |
| 1→2,4 | 3.1 | 5.1 | |
| Gal | T | 1.4 | 4.3 |
| 1→4 | 4.5 | 9.2 | |
| 1→3 | 5.9 | 12 | |
| 1→6 | 3.1 | 6.3 | |
| 1→3,6 | 2.8 | 5.6 | |
| GalA | T | 1.7 | N.D 1 |
| 1→4 | 67.9 | 37.8 |
1 N.D., not detected.
Figure 2Cell viability of Peyer’s patch cells. Cell viability was expressed as the absorption value in 450 nm according to the manufacturer’s instructions for CCK-8 kits. The different marked letters indicate a significant difference, p < 0.05.
Figure 3IL-6 secretion in the supernatant culture of Peyer’s patch cells. The different marked letters indicate a significant difference, p < 0.05.
Figure 4Immune organ indexes of C3H/HeJ mice treated with WCP-I and WCP-Ia. The different marked letters indicate a significant difference, p < 0.05.
Figure 5Cytokine secretion in serum of C3H/HeJ mice treated with WCP-I and WCP-Ia. The different marked letters indicate a significant difference, p < 0.05.
Figure 6sIgA secretion of C3H/HeJ mice treated with WCP-I and WCP-Ia. All the values show sIgA concentration in ileum tissues, and the different marked letters indicate a significant difference, p < 0.05.
Peyer’s patch cell subsets detected by flow cytometry.
| Groups | T Cells (%) | B Cells (%) | CD4 (%) | CD8a (%) | CD4/CD8a |
|---|---|---|---|---|---|
| ConA | 67.85 ± 0.35 | 83.70 ± 2.98 | 72.55 ± 1.77 | 95.00 ± 0.71 | 0.76 ± 0.01 a |
| WCP-I | 64.75 ± 3.18 | 80.43 ± 4.05 | 76.40 ± 0.14 | 95.60 ± 1.41 | 0.80 ± 0.01 ab |
| WCP-Ia | 67.30 ± 1.27 | 78.90 ± 2.63 | 76.90 ± 1.84 | 95.05 ± 0.21 | 0.81 ± 0.02 b |
Different marked letters indicate a significant difference, p < 0.05.
Group design of cell culture.
| Groups | T Cells (%) | ConA | Final Sample Concentration/(μg/mL) |
|---|---|---|---|
| Cell | Cell control | - | - |
| ConA | Control group | + | - |
| WCP-I | WCP-I | + | 20 |
| + | 10 | ||
| + | 5 | ||
| WCP-Ia | Different dosage of the pectinase digested product of WCP-I | + | 20 |
| + | 10 | ||
| + | 5 | ||
| WCP-Ib | Different dosage of the exo- | + | 20 |
| + | 10 | ||
| + | 5 | ||
| WCP-Ic | Different dosage of the digested product of endo-1,4-β-galactanase WCP-Ib | + | 20 |
| + | 10 | ||
| + | 5 |